Artificial Heart-Lung Machine Market Report by Type (Single Roller Pump, Double Roller Pump), Application (Cardiac Surgeries, Lung Surgeries, Acute Respiratory Failure Treatment, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, and Others), 2023-2028
The global artificial heart-lung machine market size reached US$ 282.7 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 351.6 Million by 2028, exhibiting a growth rate (CAGR) of 3.6% during 2023-2028.
Artificial Heart-Lung Machine Market Size in 2022
US$ 282.7 Million
Artificial Heart-Lung Machine Market Forecast in 2028
An artificial heart-lung machine, also known as a cardiopulmonary bypass (CPB) or oxygenator pump, is used during coronary artery bypass, heart and lung transplants, and other cardiac surgeries. It temporarily performs the functions of the heart and lungs to enable the surgeon to operate in motion and bloodless surgical field. These machines consist of a chamber that receives blood, which is then oxygenated and circulated to all body parts. Over the years, these pumps have helped in making significant advances in the management of severe respiratory failure as well as in the field of car-diac surgeries.
In recent years, there has been a significant rise in the number of open-heart surgeries, heart transplants and lung surgeries across the globe. This can primarily be attributed to various environmental and lifestyle changes, which have led to an increase in the prevalence of cardiovascular diseases and the instances of organ failures. Other than this, governments of several developing nations are making efforts for providing improved healthcare facilities to patients, which is driving the demand for artificial heart-lung machines. Furthermore, the market players are investing in research and development activities to modernize the current models of oxygenator pumps. These activities have led to the development of modular heart-lung machines that are cost-effective, safe, and user-friendly in nature. Besides this, these machines also offer flexibility to doctors as they are portable and can be operated on rechargeable batteries. The manufacturers have also made several improvements in CPB pumps to prevent the over-oxygenation of blood.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global artificial heart-lung machine market report, along with forecasts at the global and regional level from 2023-2028. Our report has categorized the market based on type, application and end user.
Breakup by Type:
Single Roller Pump
Double Roller Pump
Breakup by Application:
Acute Respiratory Failure Treatment
Breakup by End User:
Hospitals and Clinics
Ambulatory Surgical Centers
Breakup by Region:
Middle East and Africa
The report has also analysed the competitive landscape of the market with some of the key players being Medtronic Inc., Sorin Group, MAQUET GmbH & Co KG, Terumo Corporation, C.R. Bard Inc., Tianjin Welcome Medical Equipment Co., Ltd., Edwards Lifesciences, Jarvik Heart Inc., Braile Biomedica, SynCardia Systems, LLC, etc.
Base Year of the Analysis
Type, Application, End User, Region
Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
Post-Sale Analyst Support
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)
Key Questions Answered in This Report
The global artificial heart-lung machine market was valued at US$ 282.7 Million in 2022.
We expect the global artificial heart-lung machine market to exhibit a CAGR of 3.6% during 2023-2028.
The growing instances of organ failures and cardiovascular diseases, along with the rising focus towards providing advanced healthcare facilities to patients, are primarily driving the global artificial heart-lung machine market.
The sudden outbreak of the COVID-19 pandemic has led to the increasing utilization of artificial heart-lung machine in the management of severe respiratory failure and in the field of cardiac surgeries, to treat coronary and respiratory side-effects among the coronavirus-infected patients.
Based on the type, the global artificial heart-lung machine market can be segmented into single roller pump and double roller pump. Currently, single roller pump holds the majority of the total market share.
Based on the application, the global artificial heart-lung machine market has been divided into cardiac surgeries, lung surgeries, acute respiratory failure treatment, and others. Among these, cardiac surgeries currently exhibit a clear dominance in the market.
Based on the end user, the global artificial heart-lung machine market can be categorized into hospitals and clinics, ambulatory surgical centers, and others. Currently, hospitals and clinics account for the largest market share.
On a regional level, the market has been classified into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America, where North America currently dominates the global market.
Some of the major players in the global artificial heart-lung machine market include Medtronic Inc., Sorin Group, MAQUET GmbH & Co KG, Terumo Corporation, C.R. Bard Inc., Tianjin Welcome Medical Equipment Co., Ltd., Edwards Lifesciences, Jarvik Heart Inc., Braile Biomedica, SynCardia Systems, LLC, etc.
Need more help?
Speak to our experienced analysts for insights on the current market scenarios.
Include additional segments and countries to customize the report as per your requirement.
Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
For further assistance, please connect with our analysts.
Gain a deeper dive into a specific application, geography, customer, or competitor
Any level of personalization
Get in Touch With Us
IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.
The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required
We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra
The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.
I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.
We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.